Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM150 for VTE Prevention in Total Knee Replacement
NCT00408239Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2006
- Primary completion
- Mar 2009
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of darexaban in venous thromboembolism (VTE), sponsored by Astellas Pharma. Started Dec 2006; status: completed.
02
Drugs
darexaban
03
Conditions
venous thromboembolism (VTE)
Beyond the preview
Go deeper on NCT00408239.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00408239.